Integral Ad Science Holding Corp. (NASDAQ:IAS) Shares Sold by Algert Global LLC

Algert Global LLC cut its stake in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 79.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,779 shares of the company's stock after selling 314,792 shares during the period. Algert Global LLC owned approximately 0.05% of Integral Ad Science worth $864,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Alyeska Investment Group L.P. acquired a new position in shares of Integral Ad Science during the 4th quarter valued at $41,543,000. Dimensional Fund Advisors LP grew its holdings in Integral Ad Science by 18.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock worth $39,567,000 after acquiring an additional 580,323 shares during the period. Ararat Capital Management LP raised its position in Integral Ad Science by 13.4% in the fourth quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock worth $23,823,000 after acquiring an additional 269,346 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Integral Ad Science by 47.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company's stock valued at $7,756,000 after acquiring an additional 231,271 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Integral Ad Science by 2.3% during the 4th quarter. Vanguard Group Inc. now owns 9,048,546 shares of the company's stock valued at $94,467,000 after purchasing an additional 205,562 shares in the last quarter. Institutional investors and hedge funds own 95.78% of the company's stock.

Insiders Place Their Bets

In other news, CEO Lisa Utzschneider sold 8,367 shares of the stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $7.37, for a total transaction of $61,664.79. Following the transaction, the chief executive officer now owns 349,574 shares of the company's stock, valued at approximately $2,576,360.38. This represents a 2.34 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders sold 86,222 shares of company stock valued at $636,252 over the last ninety days. Corporate insiders own 2.00% of the company's stock.

Integral Ad Science Trading Down 0.9 %

Shares of NASDAQ:IAS opened at $7.72 on Friday. The firm has a fifty day moving average of $7.86 and a two-hundred day moving average of $9.74. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. Integral Ad Science Holding Corp. has a 12-month low of $6.26 and a 12-month high of $13.62. The firm has a market capitalization of $1.26 billion, a P/E ratio of 38.60, a price-to-earnings-growth ratio of 1.06 and a beta of 1.55.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its earnings results on Friday, February 28th. The company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $153.00 million during the quarter, compared to analysts' expectations of $148.83 million. During the same quarter last year, the firm earned $0.06 EPS. The business's revenue for the quarter was up 13.9% compared to the same quarter last year. On average, equities analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on IAS. Benchmark reiterated a "hold" rating on shares of Integral Ad Science in a report on Friday, February 28th. Morgan Stanley decreased their target price on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. Robert W. Baird reaffirmed a "neutral" rating and set a $9.00 target price (down from $16.00) on shares of Integral Ad Science in a report on Friday, March 28th. Oppenheimer restated an "outperform" rating on shares of Integral Ad Science in a report on Friday, February 28th. Finally, Stifel Nicolaus decreased their target price on shares of Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Integral Ad Science has a consensus rating of "Moderate Buy" and an average target price of $13.15.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.